GlassScriptPhysician profile
Alina Kogan
NPI 1730676826
$1,905.66
in general payments reported to CMS, 2019-2025
9 companies · $655 in 2025
The $655 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $890 · 2024: $361 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371 · Travel and Lodging: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.75 |
| Travel and Lodging | $534.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $778.53 | 2023-2024 | |
| Smith+Nephew, INC. | $287.11 | 2023-2025 | Regranex, Pico, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Organogenesis INC. | $229.37 | 2024-2025 | Apligraf, Puraply Wound Matrix |
| Angiodynamics, INC. | $179.98 | 2024 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $134.57 | 2025 | Esprit |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $121.03 | 2025 | Jublia |
| Bioventus LLC | $111.51 | 2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $46.89 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Averitas Pharma INC. | $16.67 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alina Kogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.